, and there is general agreement that the results obtained by the use of these reagents correlate well with data obtained using [H)-thymidine (Van Furth and Van Zwet, 1988; Dc Fazio et al., 1987; Schutte et al., 1987; Raza et al., 1985; Dean et al., 1984) .
In the present report we describe the production of a new anti- 
Enzyme Substrates
The substrate for the immunoperoxidase reaction was prepared by dissolv- 
In Vitro Labeling of Cells with Bromodeoxuridine
Cell suspensions were incubated for 30 mm at 37'C at a concentration of 1 x 106 cells/mI with BrdU (final concentration 0.1-10 zm). The cells were then washed and cytocentrifuged onto clean glass slides. In the case of tonsil cell suspensions the cells were separated on a Triosil Ficoll gradient before cytocentrifugation.
In some experiments
BrdU was added directly to EDTA-anticoagulated fresh human bone marrow (to give a final concentration of 10 Ism) and More cells are labeled by the latter antibody than by MAb Bu2Oa. Double labeling for these two markers is illustrated in Figure 9 . Bars = 20 pm. ,;
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, ' _________ 1520 MAGAUD, SARGENT, CLARKE, FRENCH, RIMOKH, MASON incubated for 30 mm at 37'C. Marrow smears were then prepared in a routine fashion.
All slides were stored unfixed in the frozen state until use.
In Vivo Labeling with Bromodeoxyuridine
Mice or rats were given an intravenous or intraperitoneal injection of BrdU at a dose of I mg/kg body weight. After 30-90 mm the animals were sacrificed and the required tissues removed. These were snap-frozen or, in a few instances, fixed in formalin-saline and processed to paraffin or epoxy resin as for routine histopathology.
Immunocytochemical Labeling
Fixation. Cytospin preparations were fixed in acetone or ethanol for 10 mm and cryostat sections in acetone for 10 mm before air-drying. -.1 ...., Figure 10 . Paired staining ofa cryostatsection from the thymusofa BrdU-injected ratfor Class Il histocompatibility antigen (immunoperoxidase)and BrdU incorporation (immunofluorescence).
Results

Production of Monoclonal Anti-BrdU
W .r=
(a) Staining for Class II antigen shows an extensive epithelial meshwork in the cortex, interrupted by a number of lacunae (arrows). M, medulla.
(b) Same area viewed by fluorescent illumination to reveal cells that have incorporated BrdU. Labeled nuclei are scattered throughout the thymic cortex, including the epithelial-free zones, but the medulla is largely unlabeled. 
